Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: a case report and literatures review
Y Liu - Cancer biology & therapy, 2018 - Taylor & Francis
Epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly
improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients …
improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients …
Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review
Y Liu - Cancer biology & therapy, 2018 - pubmed.ncbi.nlm.nih.gov
Epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly
improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients …
improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients …
[HTML][HTML] Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review
Y Liu - Cancer Biology & Therapy, 2018 - ncbi.nlm.nih.gov
Epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly
improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients …
improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients …
Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review.
Y Liu - Cancer Biology & Therapy, 2018 - europepmc.org
Epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly
improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients …
improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients …